The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl
- 30 April 2009
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Cell Biology
- Vol. 21 (2), 288-295
- https://doi.org/10.1016/j.ceb.2009.01.014
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Type-II Kinase Inhibitor Docking, Screening, and Profiling Using Modified Structures of Active Kinase StatesJournal of Medicinal Chemistry, 2008
- A quantitative analysis of kinase inhibitor selectivityNature Biotechnology, 2008
- Patterns of somatic mutation in human cancer genomesNature, 2007
- Nature Chemical Biology, 2006
- Features of Selective Kinase InhibitorsCell Chemical Biology, 2005
- Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibitionNature Structural & Molecular Biology, 2004
- The Protein Kinase Complement of the Human GenomeScience, 2002
- The Conformational Plasticity of Protein KinasesCell, 2002
- Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinasesTrends in Pharmacological Sciences, 1989
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986